• About us
• Contact

Advertisement

Organisation › Details

Genomic Health Inc. (Nasdaq: GHDX)

Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched its first test, Oncotype DX(TM), which is used for early stage breast cancer patients to predict the likelihood of cancer recurrence, the likelihood of patient survival within ten years of diagnosis and the likelihood of chemotherapy benefit. The company was founded in 2000 and is located in Redwood City, California. *

 

	Start	2000-08-01 established
	Group	Exact Sciences (Group)
	Industry	molecular diagnostics
	Industry 2	pharmacogenomics/pharmacogenetics
	Person	Popovits, Kimberly J. (Kim) (Genomic Health 200901– CEO before COO since 200202 before Genentech)
	Region	Redwood City, CA
	Country	United States (USA)
	Street	301 Penobscot Drive
	City	94063 Redwood City, CA
	Tel	+1-650-556-9300
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
	Currency	USD
	Annual sales	29,174,000 (revenues, total, consolidated (2006) 2006-12-31)
	Profit	-28,920,000 (2006-12-31)
	Cash	44,215,000 (2006-12-31)
		* Document for »About Section«:
		Record changed: 2023-07-10

Advertisement

More documents for Exact Sciences (Group)

• [1] MDxHealth S.A.. (8/2/22). "Press Release: MDxHealth Acquires Oncotype DX GPS Prostate Cancer Business from Exact Sciences and Reports Preliminary Half Year 2022 Results". Irvine, CA & Herstal....
• [2] Thrive Earlier Detection Corporation. (10/27/20). "Press Release: Exact Sciences to Acquire Thrive Earlier Detection, Becoming a Leader in Blood-Based, Multi-Cancer Screening". Madison, WI & Cambridge, MA....
• [3] Base Genomics Ltd.. (6/3/20). "Press Release: Base Genomics Announces Company Launch and Raises $11 Million USD to Commercialize Epigenetic Technology for Early and Sensitive Detection of Cancer from Liquid Biopsy". Oxford....
• [4] Thrive Earlier Detection Corporation. (8/1/19). "Press Release: Thrive Earlier Detection Announces Appointment of David J. Daly as Chief Executive Officer". Cambridge, MA....
• [5] Exact Sciences Corporation. (7/29/19). "Press Release: Exact Sciences and Genomic Health to Combine, Creating Leading Global Cancer Diagnostics Company". Madison, WI & Redwood City, CA....
• [6] Biocartis Group N.V.. (12/3/18). "Press Release: Genomic Health and Biocartis Expand Collaboration to Urology with the Development of an Idylla Oncotype DX Genomic Prostate Score Test". Redwood City, CA & Mechelen....
• [7] Biocartis Group N.V.. (11/28/17). "Press Release: Biocartis Launches Equity Placement [Not for US, AU, CA, JP, ZA or any other jurisdition where prohibited by law]". Mechelen....
• [8] Biocartis Group N.V.. (11/16/17). "Press Release: Biocartis Q3 2017 Business Update". Mechelen....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.